Article Details
Retrieved on: 2023-10-23 18:27:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Treatment with mRNA-4157 plus pembrolizumab yields benefits in resected melanoma subgroups in the phase 2 KEYNOTE-942 trial, including those with ...
Article found on: www.cancernetwork.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here